» Articles » PMID: 19048193

Clinical Implications of Architectural Distortion Visualized by Breast Ultrasonography

Overview
Journal Breast Cancer
Specialty Oncology
Date 2008 Dec 3
PMID 19048193
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, Architectural distortion (AD) has been detected via ultrasonography (US) even in the absence of a definitive mass; however, the clinical significance of this finding is yet unknown. The purpose of this study is to elucidate the causes of AD, as revealed by US.

Methods: Breast echo was undergone by 931 patients between January and December 2005. The study comprised 45 patients (4.8%) in the age range of 28-76 years (mean 49.8 years) whose images revealed AD despite the absence of mass formation. To investigate the causes of this AD, we retrospectively reviewed the medical records of these patients.

Results: In 10 of 45 cases in which US revealed AD, the distortion was attributed to the biopsy procedures. Of these ten patients, seven underwent Mammotome biopsy, two underwent open biopsy; one underwent core-needle biopsy. Seven patients had previous histories of neoadjuvant chemotherapy for breast cancer. Fifteen lesions were benign, and 13 lesions were malignant disease pathologically.

Conclusions: Emphasis on the increasing value of AD detection by US and professional awareness of this fact are of tremendous importance.

Citing Articles

Approach to Nonmass Lesions on Breast Ultrasound.

Mohan S, Dhamija E, Gauba R Indian J Radiol Imaging. 2024; 34(4):677-687.

PMID: 39318554 PMC: 11419763. DOI: 10.1055/s-0044-1779589.


Beyond BI-RADS: Nonmass Abnormalities on Breast Ultrasound.

Tsunoda H, Moon W Korean J Radiol. 2024; 25(2):134-145.

PMID: 38238012 PMC: 10831301. DOI: 10.3348/kjr.2023.0769.


The Japan Society of Ultrasonics in Medicine guidelines on non-mass abnormalities of the breast.

Ito T, Ueno E, Endo T, Omoto K, Kuwajima A, Taniguchi N J Med Ultrason (2001). 2023; 50(3):331-339.

PMID: 37261555 PMC: 10354171. DOI: 10.1007/s10396-023-01308-9.


Polarized Micro-Raman Spectroscopy and 2D Convolutional Neural Network Applied to Structural Analysis and Discrimination of Breast Cancer.

Shang L, Tang J, Wu J, Shang H, Huang X, Bao Y Biosensors (Basel). 2023; 13(1).

PMID: 36671896 PMC: 9856190. DOI: 10.3390/bios13010065.


Re-evaluation of high-risk breast mammography lesions by target ultrasound and ABUS of breast non-mass-like lesions.

Zhang J, Cai L, Chen L, Pang X, Chen M, Yan D BMC Med Imaging. 2021; 21(1):156.

PMID: 34702200 PMC: 8549220. DOI: 10.1186/s12880-021-00665-6.